A Phase II Trial of Docetaxel, Cetuximab (C225), and Cisplatin Followed by Radiation, Cetuximab, and Cisplatin in Locally Advanced Head and Neck Cancer.
Phase of Trial: Phase II
Latest Information Update: 13 Jul 2017
At a glance
- Drugs Cetuximab (Primary) ; Cisplatin; Docetaxel
- Indications Head and neck cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 24 Jul 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Oct 2008 Status changed from active, no longer recruiting to suspended.